The Effect of Substance P on an Intervertebral Disc Rat Organ Culture Model

STUDY DESIGN.Laboratory study. OBJECTIVE.Evaluate the effect of substance P (SP) on an intervertebral disc rat organ culture model. SUMMARY OF BACKGROUND DATA.Monolayer cell experiments have demonstrated that exposure intervertebral disc tissue cells to SP leads to upregulation in inflammatory cytok...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Spine (Philadelphia, Pa. 1976) Pa. 1976), 2016-12, Vol.41 (24), p.1851-1859
Hauptverfasser: Koerner, John D., Markova, Dessislava Z., Schroeder, Gregory D., Rihn, Jeffery A., Hilibrand, Alan S., Vaccaro, Alexander R., Anderson, D. Greg, Kepler, Christopher K.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:STUDY DESIGN.Laboratory study. OBJECTIVE.Evaluate the effect of substance P (SP) on an intervertebral disc rat organ culture model. SUMMARY OF BACKGROUND DATA.Monolayer cell experiments have demonstrated that exposure intervertebral disc tissue cells to SP leads to upregulation in inflammatory cytokine expression; however, this has not been evaluated in a more complex organ culture model. METHODS.Forty-eight intervertebral discs from eight rats were used in an organ culture model. Intervertebral discs were divided into three groupscontrol, SP-treated group, and a group treated with an SP antagonist followed by SP. Cytokine antibody array was used to quantify expression patterns, which were confirmed using ELISA and real-time polymerase chain reaction. RESULTS.The cytokine array demonstrated a 3.40 ±  0.59-fold increase in interleukin 6 (IL-6) expression in the SP group (P = 0.004), and the effect of SP was mitigated by the SP antagonist (P = 0.03). These results were verified as ELISA demonstrated a significant difference in the IL-6 level between the control group and SP group (0.73 vs. 5.80 ng/mL, P 
ISSN:0362-2436
1528-1159
DOI:10.1097/BRS.0000000000001676